Skeletal muscle-targeted peptide MSP

The MSP peptide (ASSLNIA) is a muscle-targeting ligand for selective delivery in research. It is utilized in both in vitro and in vivo studies to investigate cardiac and skeletal muscle pathologies, including muscular dystrophy and heart failure models.